instruction stringlengths 34 186 | input stringlengths 2.02k 93.8k | output stringlengths 2 418 | meta_questiontype stringclasses 6
values | meta_inputlicense stringclasses 6
values | meta_pmid stringlengths 8 8 | meta_safetyreportid int64 9.51M 21M | meta_articlepubdate stringlengths 4 10 |
|---|---|---|---|---|---|---|---|
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Sensorimotor disorder'. | Sensorimotor Polyneuropathy in a Diabetic Patient After Rapid Overcorrection of Chronic Hyperglycemia.
The differential diagnosis for peripheral neuropathy of uncertain etiology is extensive, and the work-up presents a diagnostic challenge for the physician. Following initial clinical assessment, we recommend electrodi... | ATORVASTATIN, HYDROCHLOROTHIAZIDE\LISINOPRIL, INSULIN DEGLUDEC, METFORMIN HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC | 34654335 | 20,164,389 | 2021 |
What was the outcome of reaction 'Diabetic neuropathy'? | Sensorimotor Polyneuropathy in a Diabetic Patient After Rapid Overcorrection of Chronic Hyperglycemia.
The differential diagnosis for peripheral neuropathy of uncertain etiology is extensive, and the work-up presents a diagnostic challenge for the physician. Following initial clinical assessment, we recommend electrodi... | Recovering | ReactionOutcome | CC BY-NC | 34654335 | 20,067,874 | 2021 |
What was the outcome of reaction 'Hypoaesthesia'? | Sensorimotor Polyneuropathy in a Diabetic Patient After Rapid Overcorrection of Chronic Hyperglycemia.
The differential diagnosis for peripheral neuropathy of uncertain etiology is extensive, and the work-up presents a diagnostic challenge for the physician. Following initial clinical assessment, we recommend electrodi... | Recovering | ReactionOutcome | CC BY-NC | 34654335 | 20,078,145 | 2021 |
What was the outcome of reaction 'Hypoglycaemia'? | Sensorimotor Polyneuropathy in a Diabetic Patient After Rapid Overcorrection of Chronic Hyperglycemia.
The differential diagnosis for peripheral neuropathy of uncertain etiology is extensive, and the work-up presents a diagnostic challenge for the physician. Following initial clinical assessment, we recommend electrodi... | Recovering | ReactionOutcome | CC BY-NC | 34654335 | 20,067,874 | 2021 |
What was the outcome of reaction 'Loss of personal independence in daily activities'? | Sensorimotor Polyneuropathy in a Diabetic Patient After Rapid Overcorrection of Chronic Hyperglycemia.
The differential diagnosis for peripheral neuropathy of uncertain etiology is extensive, and the work-up presents a diagnostic challenge for the physician. Following initial clinical assessment, we recommend electrodi... | Recovering | ReactionOutcome | CC BY-NC | 34654335 | 20,164,389 | 2021 |
What was the outcome of reaction 'Muscular weakness'? | Sensorimotor Polyneuropathy in a Diabetic Patient After Rapid Overcorrection of Chronic Hyperglycemia.
The differential diagnosis for peripheral neuropathy of uncertain etiology is extensive, and the work-up presents a diagnostic challenge for the physician. Following initial clinical assessment, we recommend electrodi... | Recovering | ReactionOutcome | CC BY-NC | 34654335 | 20,078,145 | 2021 |
What was the outcome of reaction 'Paraesthesia'? | Sensorimotor Polyneuropathy in a Diabetic Patient After Rapid Overcorrection of Chronic Hyperglycemia.
The differential diagnosis for peripheral neuropathy of uncertain etiology is extensive, and the work-up presents a diagnostic challenge for the physician. Following initial clinical assessment, we recommend electrodi... | Recovering | ReactionOutcome | CC BY-NC | 34654335 | 20,078,145 | 2021 |
What was the outcome of reaction 'Peripheral motor neuropathy'? | Sensorimotor Polyneuropathy in a Diabetic Patient After Rapid Overcorrection of Chronic Hyperglycemia.
The differential diagnosis for peripheral neuropathy of uncertain etiology is extensive, and the work-up presents a diagnostic challenge for the physician. Following initial clinical assessment, we recommend electrodi... | Recovering | ReactionOutcome | CC BY-NC | 34654335 | 20,164,389 | 2021 |
What was the outcome of reaction 'Peripheral sensorimotor neuropathy'? | Sensorimotor Polyneuropathy in a Diabetic Patient After Rapid Overcorrection of Chronic Hyperglycemia.
The differential diagnosis for peripheral neuropathy of uncertain etiology is extensive, and the work-up presents a diagnostic challenge for the physician. Following initial clinical assessment, we recommend electrodi... | Recovering | ReactionOutcome | CC BY-NC | 34654335 | 20,067,874 | 2021 |
What was the outcome of reaction 'Sensorimotor disorder'? | Sensorimotor Polyneuropathy in a Diabetic Patient After Rapid Overcorrection of Chronic Hyperglycemia.
The differential diagnosis for peripheral neuropathy of uncertain etiology is extensive, and the work-up presents a diagnostic challenge for the physician. Following initial clinical assessment, we recommend electrodi... | Recovering | ReactionOutcome | CC BY-NC | 34654335 | 20,164,389 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Bone marrow granuloma'. | Difficulties in Diagnosing and Treating Disseminated Bacillus Calmette-Guérin (BCG) Infection After Intravesical BCG Therapy in a Patient with Liver Cirrhosis: A Case Report.
BACKGROUND Bladder cancer (BC) is the second most common cancer involving the urinary system. In non-muscle-invading BC, transurethral resection ... | BACILLUS CALMETTE-GUERIN SUBSTRAIN TICE LIVE ANTIGEN | DrugsGivenReaction | CC BY-NC-ND | 34654796 | 20,472,027 | 2021-10-16 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Disseminated Bacillus Calmette-Guerin infection'. | Difficulties in Diagnosing and Treating Disseminated Bacillus Calmette-Guérin (BCG) Infection After Intravesical BCG Therapy in a Patient with Liver Cirrhosis: A Case Report.
BACKGROUND Bladder cancer (BC) is the second most common cancer involving the urinary system. In non-muscle-invading BC, transurethral resection ... | BACILLUS CALMETTE-GUERIN SUBSTRAIN TICE LIVE ANTIGEN | DrugsGivenReaction | CC BY-NC-ND | 34654796 | 20,472,027 | 2021-10-16 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hepatic cirrhosis'. | Difficulties in Diagnosing and Treating Disseminated Bacillus Calmette-Guérin (BCG) Infection After Intravesical BCG Therapy in a Patient with Liver Cirrhosis: A Case Report.
BACKGROUND Bladder cancer (BC) is the second most common cancer involving the urinary system. In non-muscle-invading BC, transurethral resection ... | BACILLUS CALMETTE-GUERIN SUBSTRAIN TICE LIVE ANTIGEN | DrugsGivenReaction | CC BY-NC-ND | 34654796 | 20,472,027 | 2021-10-16 |
What was the administration route of drug 'BACILLUS CALMETTE-GUERIN SUBSTRAIN TICE LIVE ANTIGEN'? | Difficulties in Diagnosing and Treating Disseminated Bacillus Calmette-Guérin (BCG) Infection After Intravesical BCG Therapy in a Patient with Liver Cirrhosis: A Case Report.
BACKGROUND Bladder cancer (BC) is the second most common cancer involving the urinary system. In non-muscle-invading BC, transurethral resection ... | Intravesical | DrugAdministrationRoute | CC BY-NC-ND | 34654796 | 20,472,027 | 2021-10-16 |
What was the outcome of reaction 'Disseminated Bacillus Calmette-Guerin infection'? | Difficulties in Diagnosing and Treating Disseminated Bacillus Calmette-Guérin (BCG) Infection After Intravesical BCG Therapy in a Patient with Liver Cirrhosis: A Case Report.
BACKGROUND Bladder cancer (BC) is the second most common cancer involving the urinary system. In non-muscle-invading BC, transurethral resection ... | Recovered | ReactionOutcome | CC BY-NC-ND | 34654796 | 20,472,027 | 2021-10-16 |
What was the outcome of reaction 'Hepatic cirrhosis'? | Difficulties in Diagnosing and Treating Disseminated Bacillus Calmette-Guérin (BCG) Infection After Intravesical BCG Therapy in a Patient with Liver Cirrhosis: A Case Report.
BACKGROUND Bladder cancer (BC) is the second most common cancer involving the urinary system. In non-muscle-invading BC, transurethral resection ... | Recovering | ReactionOutcome | CC BY-NC-ND | 34654796 | 20,472,027 | 2021-10-16 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hypercapnia'. | Veno-venous extracorporeal membrane oxygenation in the management of refractory bilateral bronchial dehiscence after lung transplant: a case report.
BACKGROUND
Bronchial dehiscence is a life-threatening complication after lung transplant. If it is not treated by placement of stent or reanastomosis, the chance of surviv... | DEXMEDETOMIDINE, MORPHINE, NITRIC OXIDE, PROPOFOL | DrugsGivenReaction | CC BY | 34654984 | 20,127,825 | 2021-10-16 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Product use in unapproved indication'. | Veno-venous extracorporeal membrane oxygenation in the management of refractory bilateral bronchial dehiscence after lung transplant: a case report.
BACKGROUND
Bronchial dehiscence is a life-threatening complication after lung transplant. If it is not treated by placement of stent or reanastomosis, the chance of surviv... | DEXMEDETOMIDINE, MORPHINE, NITRIC OXIDE, PROPOFOL | DrugsGivenReaction | CC BY | 34654984 | 20,127,825 | 2021-10-16 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Product use issue'. | Veno-venous extracorporeal membrane oxygenation in the management of refractory bilateral bronchial dehiscence after lung transplant: a case report.
BACKGROUND
Bronchial dehiscence is a life-threatening complication after lung transplant. If it is not treated by placement of stent or reanastomosis, the chance of surviv... | DEXMEDETOMIDINE, MORPHINE, NITRIC OXIDE, PROPOFOL | DrugsGivenReaction | CC BY | 34654984 | 20,127,825 | 2021-10-16 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pulmonary haemorrhage'. | Veno-venous extracorporeal membrane oxygenation in the management of refractory bilateral bronchial dehiscence after lung transplant: a case report.
BACKGROUND
Bronchial dehiscence is a life-threatening complication after lung transplant. If it is not treated by placement of stent or reanastomosis, the chance of surviv... | DEXMEDETOMIDINE, MORPHINE, NITRIC OXIDE, PROPOFOL | DrugsGivenReaction | CC BY | 34654984 | 20,127,825 | 2021-10-16 |
What was the administration route of drug 'MORPHINE'? | Veno-venous extracorporeal membrane oxygenation in the management of refractory bilateral bronchial dehiscence after lung transplant: a case report.
BACKGROUND
Bronchial dehiscence is a life-threatening complication after lung transplant. If it is not treated by placement of stent or reanastomosis, the chance of surviv... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34654984 | 20,127,825 | 2021-10-16 |
What was the administration route of drug 'NITRIC OXIDE'? | Veno-venous extracorporeal membrane oxygenation in the management of refractory bilateral bronchial dehiscence after lung transplant: a case report.
BACKGROUND
Bronchial dehiscence is a life-threatening complication after lung transplant. If it is not treated by placement of stent or reanastomosis, the chance of surviv... | Respiratory (inhalation) | DrugAdministrationRoute | CC BY | 34654984 | 20,127,825 | 2021-10-16 |
What was the dosage of drug 'DEXMEDETOMIDINE'? | Veno-venous extracorporeal membrane oxygenation in the management of refractory bilateral bronchial dehiscence after lung transplant: a case report.
BACKGROUND
Bronchial dehiscence is a life-threatening complication after lung transplant. If it is not treated by placement of stent or reanastomosis, the chance of surviv... | 0.5 MICROGRAM/KILOGRAM, HR | DrugDosageText | CC BY | 34654984 | 20,127,825 | 2021-10-16 |
What was the dosage of drug 'MORPHINE'? | Veno-venous extracorporeal membrane oxygenation in the management of refractory bilateral bronchial dehiscence after lung transplant: a case report.
BACKGROUND
Bronchial dehiscence is a life-threatening complication after lung transplant. If it is not treated by placement of stent or reanastomosis, the chance of surviv... | 6 MILLIGRAM, HR | DrugDosageText | CC BY | 34654984 | 20,127,825 | 2021-10-16 |
What was the dosage of drug 'PROPOFOL'? | Veno-venous extracorporeal membrane oxygenation in the management of refractory bilateral bronchial dehiscence after lung transplant: a case report.
BACKGROUND
Bronchial dehiscence is a life-threatening complication after lung transplant. If it is not treated by placement of stent or reanastomosis, the chance of surviv... | 250 MILLIGRAM, HR | DrugDosageText | CC BY | 34654984 | 20,127,825 | 2021-10-16 |
What was the outcome of reaction 'Hypercapnia'? | Veno-venous extracorporeal membrane oxygenation in the management of refractory bilateral bronchial dehiscence after lung transplant: a case report.
BACKGROUND
Bronchial dehiscence is a life-threatening complication after lung transplant. If it is not treated by placement of stent or reanastomosis, the chance of surviv... | Recovering | ReactionOutcome | CC BY | 34654984 | 20,127,825 | 2021-10-16 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Results from a national survey on COVID-19-associated mucormycosis in Germany: 13 patients from six tertiary hospitals.
BACKGROUND
Most COVID-19-associated mucormycosis (CAM) cases are reported from India and neighbouring countries. Anecdotally cases from Europe have been presented.
OBJECTIVE
To estimate the disease ... | AMPHOTERICIN B, ISAVUCONAZOLE, VORICONAZOLE | DrugsGivenReaction | CC BY-NC-ND | 34655486 | 20,819,317 | 2021-10-16 |
What was the dosage of drug 'AMPHOTERICIN B'? | Results from a national survey on COVID-19-associated mucormycosis in Germany: 13 patients from six tertiary hospitals.
BACKGROUND
Most COVID-19-associated mucormycosis (CAM) cases are reported from India and neighbouring countries. Anecdotally cases from Europe have been presented.
OBJECTIVE
To estimate the disease ... | SYSTEMIC | DrugDosageText | CC BY-NC-ND | 34655486 | 20,819,317 | 2021-10-16 |
What was the dosage of drug 'VORICONAZOLE'? | Results from a national survey on COVID-19-associated mucormycosis in Germany: 13 patients from six tertiary hospitals.
BACKGROUND
Most COVID-19-associated mucormycosis (CAM) cases are reported from India and neighbouring countries. Anecdotally cases from Europe have been presented.
OBJECTIVE
To estimate the disease ... | SYSTEMIC | DrugDosageText | CC BY-NC-ND | 34655486 | 20,819,317 | 2021-10-16 |
What was the outcome of reaction 'Drug ineffective'? | Results from a national survey on COVID-19-associated mucormycosis in Germany: 13 patients from six tertiary hospitals.
BACKGROUND
Most COVID-19-associated mucormycosis (CAM) cases are reported from India and neighbouring countries. Anecdotally cases from Europe have been presented.
OBJECTIVE
To estimate the disease ... | Fatal | ReactionOutcome | CC BY-NC-ND | 34655486 | 20,819,317 | 2021-10-16 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cardiac failure'. | Central Nervous System-related Graft-versus-host Disease after Allogeneic Hematopoietic Stem Cell Transplantation.
Allogeneic hemopoietic stem cell transplantation (allo-HSCT) is the only curative therapy for refractory hematological malignancies. However, there are many treatment-related complications, including organ... | AZACITIDINE, BUSULFAN, FLUDARABINE PHOSPHATE, FLUOROURACIL, MELPHALAN, METHOTREXATE, MITOMYCIN, PREDNISOLONE, TACROLIMUS | DrugsGivenReaction | CC BY-NC-ND | 34657908 | 20,326,657 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cardio-respiratory arrest'. | Central Nervous System-related Graft-versus-host Disease after Allogeneic Hematopoietic Stem Cell Transplantation.
Allogeneic hemopoietic stem cell transplantation (allo-HSCT) is the only curative therapy for refractory hematological malignancies. However, there are many treatment-related complications, including organ... | AZACITIDINE, BUSULFAN, FLUDARABINE PHOSPHATE, FLUOROURACIL, MELPHALAN, METHOTREXATE, MITOMYCIN, PREDNISOLONE, TACROLIMUS | DrugsGivenReaction | CC BY-NC-ND | 34657908 | 20,326,657 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Central Nervous System-related Graft-versus-host Disease after Allogeneic Hematopoietic Stem Cell Transplantation.
Allogeneic hemopoietic stem cell transplantation (allo-HSCT) is the only curative therapy for refractory hematological malignancies. However, there are many treatment-related complications, including organ... | AZACITIDINE, BUSULFAN, FLUDARABINE PHOSPHATE, FLUOROURACIL, MELPHALAN, METHOTREXATE, MITOMYCIN, PREDNISOLONE, TACROLIMUS | DrugsGivenReaction | CC BY-NC-ND | 34657908 | 20,326,657 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Interstitial lung disease'. | Central Nervous System-related Graft-versus-host Disease after Allogeneic Hematopoietic Stem Cell Transplantation.
Allogeneic hemopoietic stem cell transplantation (allo-HSCT) is the only curative therapy for refractory hematological malignancies. However, there are many treatment-related complications, including organ... | AZACITIDINE, BUSULFAN, FLUDARABINE PHOSPHATE, FLUOROURACIL, MELPHALAN, METHOTREXATE, MITOMYCIN, PREDNISOLONE, TACROLIMUS | DrugsGivenReaction | CC BY-NC-ND | 34657908 | 20,326,657 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Leukoencephalopathy'. | Central Nervous System-related Graft-versus-host Disease after Allogeneic Hematopoietic Stem Cell Transplantation.
Allogeneic hemopoietic stem cell transplantation (allo-HSCT) is the only curative therapy for refractory hematological malignancies. However, there are many treatment-related complications, including organ... | AZACITIDINE, BUSULFAN, FLUDARABINE PHOSPHATE, FLUOROURACIL, MELPHALAN, METHOTREXATE, MITOMYCIN, PREDNISOLONE, TACROLIMUS | DrugsGivenReaction | CC BY-NC-ND | 34657908 | 20,326,657 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Central Nervous System-related Graft-versus-host Disease after Allogeneic Hematopoietic Stem Cell Transplantation.
Allogeneic hemopoietic stem cell transplantation (allo-HSCT) is the only curative therapy for refractory hematological malignancies. However, there are many treatment-related complications, including organ... | AZACITIDINE, BUSULFAN, FLUDARABINE PHOSPHATE, FLUOROURACIL, MELPHALAN, METHOTREXATE, MITOMYCIN, PREDNISOLONE, TACROLIMUS | DrugsGivenReaction | CC BY-NC-ND | 34657908 | 20,326,657 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Respiratory failure'. | Central Nervous System-related Graft-versus-host Disease after Allogeneic Hematopoietic Stem Cell Transplantation.
Allogeneic hemopoietic stem cell transplantation (allo-HSCT) is the only curative therapy for refractory hematological malignancies. However, there are many treatment-related complications, including organ... | AZACITIDINE, BUSULFAN, FLUDARABINE PHOSPHATE, FLUOROURACIL, MELPHALAN, METHOTREXATE, MITOMYCIN, PREDNISOLONE, TACROLIMUS | DrugsGivenReaction | CC BY-NC-ND | 34657908 | 20,326,657 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Respiratory syncytial virus infection'. | Central Nervous System-related Graft-versus-host Disease after Allogeneic Hematopoietic Stem Cell Transplantation.
Allogeneic hemopoietic stem cell transplantation (allo-HSCT) is the only curative therapy for refractory hematological malignancies. However, there are many treatment-related complications, including organ... | AZACITIDINE, BUSULFAN, FLUDARABINE PHOSPHATE, FLUOROURACIL, MELPHALAN, METHOTREXATE, MITOMYCIN, PREDNISOLONE, TACROLIMUS | DrugsGivenReaction | CC BY-NC-ND | 34657908 | 20,326,657 | 2021 |
What was the dosage of drug 'AZACITIDINE'? | Central Nervous System-related Graft-versus-host Disease after Allogeneic Hematopoietic Stem Cell Transplantation.
Allogeneic hemopoietic stem cell transplantation (allo-HSCT) is the only curative therapy for refractory hematological malignancies. However, there are many treatment-related complications, including organ... | UNK, TWO COURSES | DrugDosageText | CC BY-NC-ND | 34657908 | 20,326,657 | 2021 |
What was the dosage of drug 'PREDNISOLONE'? | Central Nervous System-related Graft-versus-host Disease after Allogeneic Hematopoietic Stem Cell Transplantation.
Allogeneic hemopoietic stem cell transplantation (allo-HSCT) is the only curative therapy for refractory hematological malignancies. However, there are many treatment-related complications, including organ... | 1 MILLIGRAM/KILOGRAM PER DAY | DrugDosageText | CC BY-NC-ND | 34657908 | 20,326,657 | 2021 |
What was the dosage of drug 'TACROLIMUS'? | Central Nervous System-related Graft-versus-host Disease after Allogeneic Hematopoietic Stem Cell Transplantation.
Allogeneic hemopoietic stem cell transplantation (allo-HSCT) is the only curative therapy for refractory hematological malignancies. However, there are many treatment-related complications, including organ... | UNK, FOR GVHD PREVENTION | DrugDosageText | CC BY-NC-ND | 34657908 | 20,326,657 | 2021 |
What was the outcome of reaction 'Cardiac failure'? | Central Nervous System-related Graft-versus-host Disease after Allogeneic Hematopoietic Stem Cell Transplantation.
Allogeneic hemopoietic stem cell transplantation (allo-HSCT) is the only curative therapy for refractory hematological malignancies. However, there are many treatment-related complications, including organ... | Fatal | ReactionOutcome | CC BY-NC-ND | 34657908 | 20,326,657 | 2021 |
What was the outcome of reaction 'Cardio-respiratory arrest'? | Central Nervous System-related Graft-versus-host Disease after Allogeneic Hematopoietic Stem Cell Transplantation.
Allogeneic hemopoietic stem cell transplantation (allo-HSCT) is the only curative therapy for refractory hematological malignancies. However, there are many treatment-related complications, including organ... | Fatal | ReactionOutcome | CC BY-NC-ND | 34657908 | 20,326,657 | 2021 |
What was the outcome of reaction 'Interstitial lung disease'? | Central Nervous System-related Graft-versus-host Disease after Allogeneic Hematopoietic Stem Cell Transplantation.
Allogeneic hemopoietic stem cell transplantation (allo-HSCT) is the only curative therapy for refractory hematological malignancies. However, there are many treatment-related complications, including organ... | Fatal | ReactionOutcome | CC BY-NC-ND | 34657908 | 20,326,657 | 2021 |
What was the outcome of reaction 'Respiratory failure'? | Central Nervous System-related Graft-versus-host Disease after Allogeneic Hematopoietic Stem Cell Transplantation.
Allogeneic hemopoietic stem cell transplantation (allo-HSCT) is the only curative therapy for refractory hematological malignancies. However, there are many treatment-related complications, including organ... | Fatal | ReactionOutcome | CC BY-NC-ND | 34657908 | 20,326,657 | 2021 |
What was the outcome of reaction 'Respiratory syncytial virus infection'? | Central Nervous System-related Graft-versus-host Disease after Allogeneic Hematopoietic Stem Cell Transplantation.
Allogeneic hemopoietic stem cell transplantation (allo-HSCT) is the only curative therapy for refractory hematological malignancies. However, there are many treatment-related complications, including organ... | Fatal | ReactionOutcome | CC BY-NC-ND | 34657908 | 20,326,657 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Lipase abnormal'. | Macrolipasemia secondary to colon cancer chemotherapy: a case report.
We reported macrolipasemia in a colon cancer patient during the chemotherapy period without any evidence of pancreatitis. A 52-year-old man formerly treated for papillary thyroid carcinoma had elevated a carcinoembryonic antigen (CEA) concentration i... | CAPECITABINE, OXALIPLATIN | DrugsGivenReaction | CC BY | 34658648 | 20,100,407 | 2021-10-15 |
What was the outcome of reaction 'Lipase abnormal'? | Macrolipasemia secondary to colon cancer chemotherapy: a case report.
We reported macrolipasemia in a colon cancer patient during the chemotherapy period without any evidence of pancreatitis. A 52-year-old man formerly treated for papillary thyroid carcinoma had elevated a carcinoembryonic antigen (CEA) concentration i... | Recovering | ReactionOutcome | CC BY | 34658648 | 20,100,407 | 2021-10-15 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Loss of consciousness'. | Conversion disorder upon emergence from general anesthesia-A case report and review of literature.
Conversion disorder (CD) is a neurological symptom that is not related to any medical or neurological disease. Symptoms can range from sensory complaints to loss of consciousness. Psychological stressors such as surgery a... | ACETAMINOPHEN, LORNOXICAM, OXYCODONE HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC-SA | 34658734 | 20,332,137 | 2021 |
What is the weight of the patient? | Conversion disorder upon emergence from general anesthesia-A case report and review of literature.
Conversion disorder (CD) is a neurological symptom that is not related to any medical or neurological disease. Symptoms can range from sensory complaints to loss of consciousness. Psychological stressors such as surgery a... | 80 kg. | Weight | CC BY-NC-SA | 34658734 | 20,332,137 | 2021 |
What was the outcome of reaction 'Loss of consciousness'? | Conversion disorder upon emergence from general anesthesia-A case report and review of literature.
Conversion disorder (CD) is a neurological symptom that is not related to any medical or neurological disease. Symptoms can range from sensory complaints to loss of consciousness. Psychological stressors such as surgery a... | Recovered | ReactionOutcome | CC BY-NC-SA | 34658734 | 20,332,137 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Tracheal dilatation'. | Tracheoesophageal fistula in a COVID-19 patient.
The number of patients requiring admission in intensive care units and prolonged invasive mechanical ventilation (MV) has increased significantly during the coronavirus disease 2019 (COVID-19) pandemic. Tracheoesophageal fistula (TEF) following prolonged invasive MV is a... | DEXAMETHASONE, ENOXAPARIN SODIUM | DrugsGivenReaction | CC BY-NC-SA | 34658736 | 20,847,670 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Tracheo-oesophageal fistula'. | Tracheoesophageal fistula in a COVID-19 patient.
The number of patients requiring admission in intensive care units and prolonged invasive mechanical ventilation (MV) has increased significantly during the coronavirus disease 2019 (COVID-19) pandemic. Tracheoesophageal fistula (TEF) following prolonged invasive MV is a... | DEXAMETHASONE, ENOXAPARIN SODIUM | DrugsGivenReaction | CC BY-NC-SA | 34658736 | 20,847,670 | 2021 |
What was the administration route of drug 'DEXAMETHASONE'? | Tracheoesophageal fistula in a COVID-19 patient.
The number of patients requiring admission in intensive care units and prolonged invasive mechanical ventilation (MV) has increased significantly during the coronavirus disease 2019 (COVID-19) pandemic. Tracheoesophageal fistula (TEF) following prolonged invasive MV is a... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-SA | 34658736 | 20,847,670 | 2021 |
What was the outcome of reaction 'Tracheal dilatation'? | Tracheoesophageal fistula in a COVID-19 patient.
The number of patients requiring admission in intensive care units and prolonged invasive mechanical ventilation (MV) has increased significantly during the coronavirus disease 2019 (COVID-19) pandemic. Tracheoesophageal fistula (TEF) following prolonged invasive MV is a... | Not recovered | ReactionOutcome | CC BY-NC-SA | 34658736 | 20,847,670 | 2021 |
What was the outcome of reaction 'Tracheo-oesophageal fistula'? | Tracheoesophageal fistula in a COVID-19 patient.
The number of patients requiring admission in intensive care units and prolonged invasive mechanical ventilation (MV) has increased significantly during the coronavirus disease 2019 (COVID-19) pandemic. Tracheoesophageal fistula (TEF) following prolonged invasive MV is a... | Not recovered | ReactionOutcome | CC BY-NC-SA | 34658736 | 20,847,670 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Blood calcitonin increased'. | Continued Discontinuation of TKI Treatment in Medullary Thyroid Carcinoma - Lessons From Individual Cases With Long-Term Follow-Up.
The tyrosine kinase inhibitors (TKI) vandetanib and cabozantinib are approved as targeted therapies in advanced medullary thyroid carcinoma (MTC) with symptoms or high tumour burden. Only ... | VANDETANIB | DrugsGivenReaction | CC BY | 34659114 | 19,993,970 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Electrocardiogram QT prolonged'. | Continued Discontinuation of TKI Treatment in Medullary Thyroid Carcinoma - Lessons From Individual Cases With Long-Term Follow-Up.
The tyrosine kinase inhibitors (TKI) vandetanib and cabozantinib are approved as targeted therapies in advanced medullary thyroid carcinoma (MTC) with symptoms or high tumour burden. Only ... | VANDETANIB | DrugsGivenReaction | CC BY | 34659114 | 19,993,970 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Mental disorder'. | Continued Discontinuation of TKI Treatment in Medullary Thyroid Carcinoma - Lessons From Individual Cases With Long-Term Follow-Up.
The tyrosine kinase inhibitors (TKI) vandetanib and cabozantinib are approved as targeted therapies in advanced medullary thyroid carcinoma (MTC) with symptoms or high tumour burden. Only ... | VANDETANIB | DrugsGivenReaction | CC BY | 34659114 | 19,993,970 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Therapy partial responder'. | Continued Discontinuation of TKI Treatment in Medullary Thyroid Carcinoma - Lessons From Individual Cases With Long-Term Follow-Up.
The tyrosine kinase inhibitors (TKI) vandetanib and cabozantinib are approved as targeted therapies in advanced medullary thyroid carcinoma (MTC) with symptoms or high tumour burden. Only ... | VANDETANIB | DrugsGivenReaction | CC BY | 34659114 | 19,993,970 | 2021 |
What was the administration route of drug 'VANDETANIB'? | Continued Discontinuation of TKI Treatment in Medullary Thyroid Carcinoma - Lessons From Individual Cases With Long-Term Follow-Up.
The tyrosine kinase inhibitors (TKI) vandetanib and cabozantinib are approved as targeted therapies in advanced medullary thyroid carcinoma (MTC) with symptoms or high tumour burden. Only ... | Oral | DrugAdministrationRoute | CC BY | 34659114 | 19,993,970 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Neoplasm progression'. | Case Report: Immune and Genomic Characteristics Associated With Hyperprogression in a Patient With Metastatic Deficient Mismatch Repair Gastrointestinal Cancer Treated With Anti-PD-1 Antibody.
Microsatellite instability-high/deficient mismatch repair (MSI-H/dMMR) status of tumors is a distinct predictive biomarker of i... | GEMCITABINE, PACLITAXEL | DrugsGivenReaction | CC BY | 34659249 | 20,898,537 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Diarrhoea'. | Clinical Experience of Proteasome Inhibitor Bortezomib Regarding Efficacy and Safety in Severe Systemic Lupus Erythematosus: A Nationwide Study.
As treatment options in advanced systematic lupus erythematosus (SLE) are limited, there is an urgent need for new and effective therapeutic alternatives for selected cases wi... | BORTEZOMIB, HYDROXYCHLOROQUINE, MYCOPHENOLATE MOFETIL, RITUXIMAB | DrugsGivenReaction | CC BY | 34659263 | 20,137,568 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hepatic enzyme increased'. | Clinical Experience of Proteasome Inhibitor Bortezomib Regarding Efficacy and Safety in Severe Systemic Lupus Erythematosus: A Nationwide Study.
As treatment options in advanced systematic lupus erythematosus (SLE) are limited, there is an urgent need for new and effective therapeutic alternatives for selected cases wi... | BORTEZOMIB, HYDROXYCHLOROQUINE, MYCOPHENOLATE MOFETIL, RITUXIMAB | DrugsGivenReaction | CC BY | 34659263 | 20,137,568 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hyperkalaemia'. | Clinical Experience of Proteasome Inhibitor Bortezomib Regarding Efficacy and Safety in Severe Systemic Lupus Erythematosus: A Nationwide Study.
As treatment options in advanced systematic lupus erythematosus (SLE) are limited, there is an urgent need for new and effective therapeutic alternatives for selected cases wi... | BORTEZOMIB, HYDROXYCHLOROQUINE, MYCOPHENOLATE MOFETIL, RITUXIMAB | DrugsGivenReaction | CC BY | 34659263 | 20,137,568 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hypernatraemia'. | Clinical Experience of Proteasome Inhibitor Bortezomib Regarding Efficacy and Safety in Severe Systemic Lupus Erythematosus: A Nationwide Study.
As treatment options in advanced systematic lupus erythematosus (SLE) are limited, there is an urgent need for new and effective therapeutic alternatives for selected cases wi... | BORTEZOMIB, HYDROXYCHLOROQUINE, MYCOPHENOLATE MOFETIL, RITUXIMAB | DrugsGivenReaction | CC BY | 34659263 | 20,137,568 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Nephrogenic anaemia'. | Clinical Experience of Proteasome Inhibitor Bortezomib Regarding Efficacy and Safety in Severe Systemic Lupus Erythematosus: A Nationwide Study.
As treatment options in advanced systematic lupus erythematosus (SLE) are limited, there is an urgent need for new and effective therapeutic alternatives for selected cases wi... | BORTEZOMIB, HYDROXYCHLOROQUINE, MYCOPHENOLATE MOFETIL, RITUXIMAB | DrugsGivenReaction | CC BY | 34659263 | 20,137,568 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pulmonary embolism'. | Clinical Experience of Proteasome Inhibitor Bortezomib Regarding Efficacy and Safety in Severe Systemic Lupus Erythematosus: A Nationwide Study.
As treatment options in advanced systematic lupus erythematosus (SLE) are limited, there is an urgent need for new and effective therapeutic alternatives for selected cases wi... | BORTEZOMIB, HYDROXYCHLOROQUINE, RITUXIMAB | DrugsGivenReaction | CC BY | 34659263 | 20,072,895 | 2021 |
What was the administration route of drug 'BORTEZOMIB'? | Clinical Experience of Proteasome Inhibitor Bortezomib Regarding Efficacy and Safety in Severe Systemic Lupus Erythematosus: A Nationwide Study.
As treatment options in advanced systematic lupus erythematosus (SLE) are limited, there is an urgent need for new and effective therapeutic alternatives for selected cases wi... | Subcutaneous | DrugAdministrationRoute | CC BY | 34659263 | 20,137,568 | 2021 |
What was the administration route of drug 'HYDROXYCHLOROQUINE'? | Clinical Experience of Proteasome Inhibitor Bortezomib Regarding Efficacy and Safety in Severe Systemic Lupus Erythematosus: A Nationwide Study.
As treatment options in advanced systematic lupus erythematosus (SLE) are limited, there is an urgent need for new and effective therapeutic alternatives for selected cases wi... | Subcutaneous | DrugAdministrationRoute | CC BY | 34659263 | 20,072,895 | 2021 |
What was the administration route of drug 'RITUXIMAB'? | Clinical Experience of Proteasome Inhibitor Bortezomib Regarding Efficacy and Safety in Severe Systemic Lupus Erythematosus: A Nationwide Study.
As treatment options in advanced systematic lupus erythematosus (SLE) are limited, there is an urgent need for new and effective therapeutic alternatives for selected cases wi... | Subcutaneous | DrugAdministrationRoute | CC BY | 34659263 | 20,072,895 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Arthralgia'. | Long-term survival after repetitive lymphadenectomy for nodal recurrence of pancreatic neuroendocrine neoplasms: a report of two cases.
Pancreatic neuroendocrine neoplasms (PNENs) are rare, but their incidence has increased in recent years. Curative surgery is recommended in several global guidelines for resectable PNE... | LANREOTIDE, SUNITINIB | DrugsGivenReaction | CC BY-NC | 34659739 | 20,718,213 | 2021-10 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Malignant neoplasm progression'. | Long-term survival after repetitive lymphadenectomy for nodal recurrence of pancreatic neuroendocrine neoplasms: a report of two cases.
Pancreatic neuroendocrine neoplasms (PNENs) are rare, but their incidence has increased in recent years. Curative surgery is recommended in several global guidelines for resectable PNE... | LANREOTIDE, SUNITINIB | DrugsGivenReaction | CC BY-NC | 34659739 | 20,718,213 | 2021-10 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pyrexia'. | Long-term survival after repetitive lymphadenectomy for nodal recurrence of pancreatic neuroendocrine neoplasms: a report of two cases.
Pancreatic neuroendocrine neoplasms (PNENs) are rare, but their incidence has increased in recent years. Curative surgery is recommended in several global guidelines for resectable PNE... | LANREOTIDE, SUNITINIB | DrugsGivenReaction | CC BY-NC | 34659739 | 20,718,213 | 2021-10 |
What was the administration route of drug 'SUNITINIB'? | Long-term survival after repetitive lymphadenectomy for nodal recurrence of pancreatic neuroendocrine neoplasms: a report of two cases.
Pancreatic neuroendocrine neoplasms (PNENs) are rare, but their incidence has increased in recent years. Curative surgery is recommended in several global guidelines for resectable PNE... | Oral | DrugAdministrationRoute | CC BY-NC | 34659739 | 20,718,213 | 2021-10 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Recombinant activated factor VII in a patient with intracranial hemorrhage and severe thrombocytopenia.
Hemorrhage in patients with hematologic malignancies is often difficult to manage as many of these patients also have coagulopathy and thrombocytopenia of varying severity. Recombinant factor VIIa is a FDA-approved a... | BORTEZOMIB, CISPLATIN, CYCLOPHOSPHAMIDE, DARATUMUMAB, DEXAMETHASONE, DOXORUBICIN, ETOPOSIDE, THALIDOMIDE | DrugsGivenReaction | CC BY-NC-ND | 34659753 | 20,108,981 | 2021-10 |
What was the outcome of reaction 'Drug ineffective'? | Recombinant activated factor VII in a patient with intracranial hemorrhage and severe thrombocytopenia.
Hemorrhage in patients with hematologic malignancies is often difficult to manage as many of these patients also have coagulopathy and thrombocytopenia of varying severity. Recombinant factor VIIa is a FDA-approved a... | Fatal | ReactionOutcome | CC BY-NC-ND | 34659753 | 20,108,981 | 2021-10 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hypoaesthesia'. | Lidocaine-induced systemic toxicity complicating radiofrequency ablation of benign thyroid nodule procedure: A case report and review of literature.
The systemic toxicity of lidocaine is an extremely rare complication of thyroid RFA procedure, and it can be life-threatening. The quick recognization of its symptoms and ... | LIDOCAINE | DrugsGivenReaction | CC BY | 34659756 | 20,013,060 | 2021-10 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Mental status changes'. | Lidocaine-induced systemic toxicity complicating radiofrequency ablation of benign thyroid nodule procedure: A case report and review of literature.
The systemic toxicity of lidocaine is an extremely rare complication of thyroid RFA procedure, and it can be life-threatening. The quick recognization of its symptoms and ... | DIPHENHYDRAMINE, EGG PHOSPHOLIPIDS\GLYCERIN\SOYBEAN OIL, EPINEPHRINE, LIDOCAINE, METHYLPREDNISOLONE, SODIUM CHLORIDE | DrugsGivenReaction | CC BY | 34659756 | 20,236,189 | 2021-10 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Toxicity to various agents'. | Lidocaine-induced systemic toxicity complicating radiofrequency ablation of benign thyroid nodule procedure: A case report and review of literature.
The systemic toxicity of lidocaine is an extremely rare complication of thyroid RFA procedure, and it can be life-threatening. The quick recognization of its symptoms and ... | LIDOCAINE | DrugsGivenReaction | CC BY | 34659756 | 20,013,060 | 2021-10 |
What was the administration route of drug 'LIDOCAINE'? | Lidocaine-induced systemic toxicity complicating radiofrequency ablation of benign thyroid nodule procedure: A case report and review of literature.
The systemic toxicity of lidocaine is an extremely rare complication of thyroid RFA procedure, and it can be life-threatening. The quick recognization of its symptoms and ... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34659756 | 20,171,265 | 2021-10 |
What was the administration route of drug 'SODIUM CHLORIDE'? | Lidocaine-induced systemic toxicity complicating radiofrequency ablation of benign thyroid nodule procedure: A case report and review of literature.
The systemic toxicity of lidocaine is an extremely rare complication of thyroid RFA procedure, and it can be life-threatening. The quick recognization of its symptoms and ... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34659756 | 20,236,189 | 2021-10 |
What was the dosage of drug 'SODIUM CHLORIDE'? | Lidocaine-induced systemic toxicity complicating radiofrequency ablation of benign thyroid nodule procedure: A case report and review of literature.
The systemic toxicity of lidocaine is an extremely rare complication of thyroid RFA procedure, and it can be life-threatening. The quick recognization of its symptoms and ... | 500 MILLILITER OF 0.9 % SALINE | DrugDosageText | CC BY | 34659756 | 20,236,189 | 2021-10 |
What was the outcome of reaction 'Bradycardia'? | Lidocaine-induced systemic toxicity complicating radiofrequency ablation of benign thyroid nodule procedure: A case report and review of literature.
The systemic toxicity of lidocaine is an extremely rare complication of thyroid RFA procedure, and it can be life-threatening. The quick recognization of its symptoms and ... | Recovered | ReactionOutcome | CC BY | 34659756 | 20,016,968 | 2021-10 |
What was the outcome of reaction 'Dizziness'? | Lidocaine-induced systemic toxicity complicating radiofrequency ablation of benign thyroid nodule procedure: A case report and review of literature.
The systemic toxicity of lidocaine is an extremely rare complication of thyroid RFA procedure, and it can be life-threatening. The quick recognization of its symptoms and ... | Recovered | ReactionOutcome | CC BY | 34659756 | 20,016,968 | 2021-10 |
What was the outcome of reaction 'Hypoaesthesia oral'? | Lidocaine-induced systemic toxicity complicating radiofrequency ablation of benign thyroid nodule procedure: A case report and review of literature.
The systemic toxicity of lidocaine is an extremely rare complication of thyroid RFA procedure, and it can be life-threatening. The quick recognization of its symptoms and ... | Recovered | ReactionOutcome | CC BY | 34659756 | 20,016,968 | 2021-10 |
What was the outcome of reaction 'Hypoaesthesia'? | Lidocaine-induced systemic toxicity complicating radiofrequency ablation of benign thyroid nodule procedure: A case report and review of literature.
The systemic toxicity of lidocaine is an extremely rare complication of thyroid RFA procedure, and it can be life-threatening. The quick recognization of its symptoms and ... | Recovered | ReactionOutcome | CC BY | 34659756 | 20,013,060 | 2021-10 |
What was the outcome of reaction 'Hypotension'? | Lidocaine-induced systemic toxicity complicating radiofrequency ablation of benign thyroid nodule procedure: A case report and review of literature.
The systemic toxicity of lidocaine is an extremely rare complication of thyroid RFA procedure, and it can be life-threatening. The quick recognization of its symptoms and ... | Recovered | ReactionOutcome | CC BY | 34659756 | 20,016,968 | 2021-10 |
What was the outcome of reaction 'Hypoxia'? | Lidocaine-induced systemic toxicity complicating radiofrequency ablation of benign thyroid nodule procedure: A case report and review of literature.
The systemic toxicity of lidocaine is an extremely rare complication of thyroid RFA procedure, and it can be life-threatening. The quick recognization of its symptoms and ... | Recovered | ReactionOutcome | CC BY | 34659756 | 20,016,968 | 2021-10 |
What was the outcome of reaction 'Local anaesthetic systemic toxicity'? | Lidocaine-induced systemic toxicity complicating radiofrequency ablation of benign thyroid nodule procedure: A case report and review of literature.
The systemic toxicity of lidocaine is an extremely rare complication of thyroid RFA procedure, and it can be life-threatening. The quick recognization of its symptoms and ... | Recovered | ReactionOutcome | CC BY | 34659756 | 20,214,668 | 2021-10 |
What was the outcome of reaction 'Mental status changes'? | Lidocaine-induced systemic toxicity complicating radiofrequency ablation of benign thyroid nodule procedure: A case report and review of literature.
The systemic toxicity of lidocaine is an extremely rare complication of thyroid RFA procedure, and it can be life-threatening. The quick recognization of its symptoms and ... | Recovered | ReactionOutcome | CC BY | 34659756 | 20,236,189 | 2021-10 |
What was the outcome of reaction 'Nausea'? | Lidocaine-induced systemic toxicity complicating radiofrequency ablation of benign thyroid nodule procedure: A case report and review of literature.
The systemic toxicity of lidocaine is an extremely rare complication of thyroid RFA procedure, and it can be life-threatening. The quick recognization of its symptoms and ... | Recovered | ReactionOutcome | CC BY | 34659756 | 20,016,968 | 2021-10 |
What was the outcome of reaction 'Peripheral coldness'? | Lidocaine-induced systemic toxicity complicating radiofrequency ablation of benign thyroid nodule procedure: A case report and review of literature.
The systemic toxicity of lidocaine is an extremely rare complication of thyroid RFA procedure, and it can be life-threatening. The quick recognization of its symptoms and ... | Recovered | ReactionOutcome | CC BY | 34659756 | 20,016,968 | 2021-10 |
What was the outcome of reaction 'Toxicity to various agents'? | Lidocaine-induced systemic toxicity complicating radiofrequency ablation of benign thyroid nodule procedure: A case report and review of literature.
The systemic toxicity of lidocaine is an extremely rare complication of thyroid RFA procedure, and it can be life-threatening. The quick recognization of its symptoms and ... | Recovered | ReactionOutcome | CC BY | 34659756 | 20,013,060 | 2021-10 |
What was the outcome of reaction 'Vision blurred'? | Lidocaine-induced systemic toxicity complicating radiofrequency ablation of benign thyroid nodule procedure: A case report and review of literature.
The systemic toxicity of lidocaine is an extremely rare complication of thyroid RFA procedure, and it can be life-threatening. The quick recognization of its symptoms and ... | Recovered | ReactionOutcome | CC BY | 34659756 | 20,016,968 | 2021-10 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Blood creatine increased'. | Lymphocutaneous Sporotrichosis Refractory to First-Line Treatment.
Sporotrichosis is a fungal infection endemic in Latin America and has been attributed to the thermodimorphic fungus of the genus Sporothrix. Transmission to humans occurs during a traumatic injury with soil or organic material; additionally, lesions cau... | AMPHOTERICIN B, DEXTROSE, ITRACONAZOLE, POTASSIUM CHLORIDE, SODIUM CHLORIDE | DrugsGivenReaction | CC BY | 34659843 | 20,091,786 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Blood potassium increased'. | Lymphocutaneous Sporotrichosis Refractory to First-Line Treatment.
Sporotrichosis is a fungal infection endemic in Latin America and has been attributed to the thermodimorphic fungus of the genus Sporothrix. Transmission to humans occurs during a traumatic injury with soil or organic material; additionally, lesions cau... | AMPHOTERICIN B, DEXTROSE, ITRACONAZOLE, POTASSIUM CHLORIDE, SODIUM CHLORIDE | DrugsGivenReaction | CC BY | 34659843 | 20,091,786 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Decreased appetite'. | Lymphocutaneous Sporotrichosis Refractory to First-Line Treatment.
Sporotrichosis is a fungal infection endemic in Latin America and has been attributed to the thermodimorphic fungus of the genus Sporothrix. Transmission to humans occurs during a traumatic injury with soil or organic material; additionally, lesions cau... | AMPHOTERICIN B, DEXTROSE, ITRACONAZOLE, POTASSIUM CHLORIDE, SODIUM CHLORIDE | DrugsGivenReaction | CC BY | 34659843 | 20,091,786 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective for unapproved indication'. | Lymphocutaneous Sporotrichosis Refractory to First-Line Treatment.
Sporotrichosis is a fungal infection endemic in Latin America and has been attributed to the thermodimorphic fungus of the genus Sporothrix. Transmission to humans occurs during a traumatic injury with soil or organic material; additionally, lesions cau... | AMPHOTERICIN B, DEXTROSE, ITRACONAZOLE, POTASSIUM CHLORIDE, SODIUM CHLORIDE | DrugsGivenReaction | CC BY | 34659843 | 20,091,786 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug intolerance'. | Lymphocutaneous Sporotrichosis Refractory to First-Line Treatment.
Sporotrichosis is a fungal infection endemic in Latin America and has been attributed to the thermodimorphic fungus of the genus Sporothrix. Transmission to humans occurs during a traumatic injury with soil or organic material; additionally, lesions cau... | ITRACONAZOLE | DrugsGivenReaction | CC BY | 34659843 | 20,017,211 | 2021 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.